Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

2025 Event

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

At Propeller Health, our mission is to empower every person living with a chronic respiratory disease to take control of their health so they can live a better life. As a leader in digital health and therapeutics for asthma and COPD, we work to improve clinical outcomes, healthcare costs, and quality of life by supporting patients in managing their condition with their healthcare provider.

Propeller’s platform includes FDA cleared medical devices, consumer apps and access to clinical data for provider monitoring throughout the care journey, to create value to all stakeholders. We enable a personalized digital experience with a human touch used by patients, caregivers, providers, payers, pharmaceutical companies and other healthcare organizations across the US, Europe and Asia.

Propeller Health is a wholly owned subsidiary of ResMed (NYSE: RMD, ASX: RMD). For more information, visit www.propellerhealth.com.

Propeller Health - HLTH 2021 Sponsor

Profility is focused on developing advanced predictive analytics solutions that enable truly personalized care planning for acute care, post-acute care (PAC) and long-term care markets. 
Profility supports the processes of discharge planning with the transition of the patient to the next care provider. The solutions help to find the right next level of care, the right provider and make sure the transition is done in the most proper way leveraging the data that is collected along the process.
Profility solutions are serving all the different players that are involved in the discharge planning and admission to the next level of care – and the impact of the solutions is notable. 
Its unique big data sets feature tens of millions of patients from Skilled Nursing Facilities (SNFs), Inpatient Rehabilitation Facilities (IRFs), Home Health Care (HHC) agencies and Long-Term Care (LTC) facilities. Profility has developed advanced, machine-learning algorithms that turn these millions of patient records into tens of thousands of profiles to form the basis of a more accurate predictive solution that generates real benefits in the field: improved care delivery, improved outcomes and significant cost savings. The state-of-the-art platform is built in a cloud environment, is fully Health Insurance Portability and Accountability Act (HIPAA)-compliant, scalable and allows for streamlined deployment.

Profility Solutions


Profility Patient Profile - Enables PAC care planning in transition, increase participation and accountability, highlight patient risks. Populate the information to the team in the facility in the right time and the right place, and open a new patient in the EMR in the most effective way. 

Profility PAC Selector - Multidimensional comparison of rehabilitation success components, determine optimal care path choice. Help to select the right next level of care and compare between different aspects in the different care setting. 

Profility PAC Provider Search - Improve discharge team throughput, personalized matching of patients to specific PAC facilities to optimize care outcomes and reduce costs. Unique techniques to keep the data up to date.

Profility Utilization (Care) Management – Monitor patients after leaving the hospital to reduce PAC length of stay, reduce readmission, optimize outcomes, and reduce overall system costs.

Profility Market Dynamics and Scorecard - Provider performance analysis, local market optimization, care and partnership quality improvements.

Profility - HLTH 2021 Sponsor

Promaxo was founded by a team of entrepreneurs and healthcare innovators to develop a minimally-invasive and patient-centric MRI and robotic platform. Based in Oakland, California, and backed by over 90 patents, the Company’s mission is to improve lives through state-of-the-art medical imaging, robotics and AI capabilities. With a compact and adaptable MRI, Promaxo is redefining the standard of care by improving the quality and speed of patient diagnosis and interventions. Recently, the Company received 510(k) clearance from the U.S. FDA for its revolutionary office-based MRI system, allowing practices and hospitals to seamlessly guide prostate interventions under the single-sided scanner. Promaxo has formed numerous long-term and strategic partnerships with investor groups and corporations as it prepares to enter the US market.

Promaxo - HLTH 2021 Sponsor

Promaxo Inc